Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis

被引：0
|
作者：
Yoshikazu Ogawa
Nobunori Takahashi
Atsushi Kaneko
Yuji Hirano
Yasuhide Kanayama
Yuichiro Yabe
Takeshi Oguchi
Takayoshi Fujibayashi
Hideki Takagi
Masahiro Hanabayashi
Koji Funahashi
Masatoshi Hayashi
Seiji Tsuboi
Shuji Asai
Nobuyuki Asai
Takuya Matsumoto
Yasumori Sobue
Naoki Ishiguro
Toshihisa Kojima
机构：
[1] Nakatsugawa Municipal General Hospital,Department of Orthopaedic Surgery
[2] Nagoya University Graduate School of Medicine,Department of Orthopaedic Surgery
[3] Nagoya Medical Center,Department of Orthopedic Surgery and Rheumatology
[4] Toyohashi Municipal Hospital,Department of Rheumatology
[5] Toyota Kosei Hospital,Department of Orthopedic Surgery
[6] Tokyo Shinjuku Medical Center,Department of Rheumatology
[7] Anjo Kosei Hospital,Department of Orthopedic Surgery
[8] Konan Kosei Hospital,Department of Orthopedic Surgery
[9] Nagoya Central Hospital,Department of Orthopedic Surgery
[10] Ichinomiya Municipal Hospital,Department of Orthopedic Surgery
[11] Kariya–Toyota General Hospital,Department of Orthopedic Surgery
[12] Nagano Red Cross Hospital,Department of Rheumatology
[13] Shizuoka Kosei Hospital,Department of Orthopedic Surgery
来源：
Clinical Rheumatology | 2019年 / 38卷
关键词：
Biological therapy; Rheumatoid factor; Tumor necrosis factor; Survival analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2757 / 2763
页数：6
相关论文
共 50 条
  • [41] Comparison of Drug Retention Rates and Causes of Drug Discontinuation Between Anti-Tumor Necrosis Factor Agents in Rheumatoid Arthritis
    Du Pan, Sophie Martin
    Dehler, Silvia
    Ciurea, Adrian
    Ziswiler, Hans-Rudolf
    Gabay, Cem
    Finckh, Axel
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05): : 560 - 568
  • [42] Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Cannon, Grant W.
    DuVall, Scott L.
    Haroldsen, Candace L.
    Caplan, Liron
    Curtis, Jeffrey R.
    Michaud, Kaleb
    Mikuls, Ted R.
    Reimold, Andreas
    Collier, David H.
    Joseph, George J.
    Harrison, David J.
    Sauer, Brian C.
    ADVANCES IN THERAPY, 2016, 33 (08) : 1347 - 1359
  • [43] Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Grant W. Cannon
    Scott L. DuVall
    Candace L. Haroldsen
    Liron Caplan
    Jeffrey R. Curtis
    Kaleb Michaud
    Ted R. Mikuls
    Andreas Reimold
    David H. Collier
    George J. Joseph
    David J. Harrison
    Brian C. Sauer
    Advances in Therapy, 2016, 33 : 1347 - 1359
  • [44] Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors
    Mewar, Devesh
    Wilson, Anthony G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (04) : 785 - 791
  • [45] Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease
    Moghadam, Marjan Ghiti
    ten Klooster, Peter M.
    Vonkeman, Harald E.
    Kneepkens, Eva L.
    Klaasen, Ruth
    Stolk, Jan N.
    Tchetverikov, Ilja
    Vreugdenhil, Simone A.
    van Woerkom, Jan M.
    Goekoop-Ruiterman, Yvonne P. M.
    Landewe, Robert B. M.
    van Riel, Piet L. C. M.
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (04) : 516 - 524
  • [46] Rheumatoid arthritis and tuberculosis in the tumor necrosis factor inhibitors era - Observations from Brazil
    Pinheiro, GDC
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (06) : 344 - 346
  • [47] Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?
    Kavanaugh, Arthur
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 346 - 347
  • [48] Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?
    Arthur Kavanaugh
    Nature Clinical Practice Rheumatology, 2006, 2 : 346 - 347
  • [49] Predictors of Treatment Initiation with Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis
    Desai, Rishi J.
    Rao, Jaya K.
    Hansen, Richard A.
    Fang, Gang
    Maciejewski, Matthew L.
    Farley, Joel F.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2014, 20 (11): : 1110 - 1120
  • [50] Ischemic Colitis During Treatment with Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis
    Salk, Allison
    Stobaugh, Derrick
    Deepak, Parakkal
    Ehrenpreis, Eli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S208 - S208
12345